Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of AD-117 in Healthy Volunteers
NCT07495514Phase 1Completed
- Sponsor
- Addpharma, Inc.
- Start
- Feb 2026
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of AD-117 in mixed dyslipidemia (2 arms), sponsored by Addpharma, Inc. Primary endpoints: Maximum concentration of drug in plasma and Area under the plasma concentration-time curve during dosing interval. Started Feb 2026; status: completed.
02
Drugs
AD-117
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT07495514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07495514.